GlassScriptPhysician profile
Aspen S Laneman
NPI 1619079274
$2,265.40
in general payments reported to CMS, 2019-2025
23 companies · $86.73 in 2025
The $86.73 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $252 · 2021: $291 · 2022: $597 · 2023: $713 · 2024: $61.20 · 2025: $86.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $1,175.41 | 2021-2023 | Xeomin |
| Abbvie INC. | $413.73 | 2019-2022 | |
| Organon LLC | $76.34 | 2022-2024 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $70.07 | 2020-2021 | |
| Therapeuticsmd, INC. | $59.17 | 2019-2021 | |
| Sanofi Pasteur INC. | $53.14 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $47.92 | 2024-2025 | Kristalose |
| Lupin INC. | $44.99 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $32.22 | 2019 | |
| Allergan, INC. | $31.24 | 2021 | |
| Mayne Pharma Commercial LLC | $29.35 | 2022 | |
| Merck Sharp & Dohme LLC | $28.47 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Aspira Women'S Health INC | $26.41 | 2020 | |
| Vertical Pharmaceuticals, LLC | $25.06 | 2019 | |
| Glaxosmithkline, LLC. | $20.51 | 2025 | Bexsero, Shingrix, Arexvy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $19.87 | 2019 | |
| Cipher Pharmaceuticals US LLC | $19.71 | 2025 | Natroba, Spinosad |
| Duchesnay USA Incorporated | $15.82 | 2019 | |
| Cranial Technologies, INC | $15.76 | 2023 | Doc Band |
| Mylan Pharmaceuticals INC. | $15.75 | 2019 | |
| Coopersurgical, INC. | $15.51 | 2021 | |
| Evofem Biosciences, INC. | $14.82 | 2025 | Solosec, Phexx, Phexxi |
| Pfizer INC. | $14.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aspen Laneman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.